CoChat

Clinical Practice Guideline: Tinnitus Update

Open access

The DOI matches its Crossref record; 352 of the 352 references it cites were found in a registry or an index; none of the 383 sources its claims cite is checked for support yet.

Abstract

Objective: Tinnitus is the perception of sound without an external source. More than 50 million people in the United States have reported experiencing tinnitus, resulting in an estimated prevalence of 10% to 15% in adults. The focus of this guideline is on tinnitus that is both bothersome and persistent (lasting 6 months or longer), which often negatively affects the patient's quality of life. The target audience for the guideline is any clinician, including allied health professionals, involved in managing patients with tinnitus. The target patient population is limited to adults (18 years and older) with tinnitus that is persistent and bothersome. Purpose: The purpose of this guideline is to provide and update evidence‐based recommendations for clinicians managing patients with tinnitus. This guideline provides clinicians with a logical framework to improve patient care and mitigate the personal and social effects of persistent, bothersome tinnitus. It discusses the evaluation of patients with tinnitus, including selection and timing of diagnostic testing and specialty referral to identify potential underlying treatable pathology. It then focuses on the treatment of patients with persistent tinnitus, with recommendations to guide the measurement of the effect of tinnitus and to determine the most appropriate interventions to improve symptoms and quality of life for people with tinnitus and associated comorbidities. Methods: This guideline was developed using the 55‐page protocol published as the American Academy of Otolaryngology–Head and Neck Surgery Foundation's Clinical Practice Guideline Development Manual (3rd edition), which summarizes the methodology for assessments of current data, topic prioritization, development of key action statements (KASs), application of value judgments, and related procedures. The guideline group was represented by adult otolaryngologists, audiologists, otologists/neurotologists, a geriatrician, a behavioral neuroscientist, a neurologist, a radiologist, a psychiatrist, an internist, a nurse practitioner, an otolaryngology resident physician, and a consumer advocate who represented participating, national professional organizations. Action Statements: The Guideline Update Group made strong recommendations for the following Key Action Statements (KAS): Clinicians should distinguish patients with bothersome tinnitus from patients with non‐bothersome tinnitus (KAS 2). Clinicians should inquire about risks for self‐harm in a patient with bothersome tinnitus (KAS 3). Clinicians should not obtain neuroradiologic imaging in patients with tinnitus specifically to evaluate the tinnitus unless specific concerning features are present (KAS 6). The Guideline Update Group made recommendations for the following KASs: Clinicians should perform a targeted history and physical examination at the initial evaluation of a patient with tinnitus (KAS 1). Clinicians should obtain a comprehensive audiological evaluation in patients with tinnitus (KAS 5). Clinicians should educate patients with tinnitus about the natural history and effects of, and management strategies for tinnitus (KAS 7). Clinicians should recommend a hearing aid evaluation for patients with hearing difficulties and persistent, bothersome tinnitus (KAS 8). Clinicians should refer patients with persistent, bothersome tinnitus for cochlear implant evaluation when they meet audiologic criteria for referral (KAS 9). Clinicians should recommend Cognitive Behavioral Therapy (CBT) to patients with persistent, bothersome tinnitus (KAS 11). Clinicians or their designee should assess and document outcomes of interventions in patients with persistent, bothersome tinnitus (KAS 15). The Guideline Update Group made recommendations against for the following KASs: Clinicians should not routinely recommend antidepressants, anticonvulsants, anxiolytics, or intratympanic medications for a primary indication of treating persistent, bothersome tinnitus (KAS 12). Clinicians should not recommend dietary supplements for the primary indication of persistent, bothersome tinnitus (KAS 13). Clinicians should not recommend repetitive transcranial magnetic stimulation (rTMS) for the treatment of patients with persistent, bothersome tinnitus (KAS 14A). The Guideline Update Group offered options for the following KASs: Clinicians may inquire about somatosensory features in patients with persistent, bothersome tinnitus (KAS 4). Clinicians may recommend sound enrichment to patients with persistent, bothersome tinnitus (KAS 10). Clinicians may offer bimodal neuromodulation to patients with persistent, bothersome tinnitus (KAS 14B).

Overview

CoChat Summary

TL;DR

This AAO-HNSF clinical practice guideline update provides evidence-based recommendations for evaluating and managing persistent, bothersome tinnitus in adults, emphasizing targeted history/exam, audiologic evaluation, education/counseling, CBT, hearing aids/cochlear implant referral, and against routine imaging, medications, supplements, and rTMS. It incorporates new evidence from 28 guidelines, 223 systematic reviews, and 362 RCTs, with new statements on self-harm, somatosensory tinnitus, cochlear implantation, bimodal neuromodulation, and follow-up.

Key findings

  • Tinnitus affects an estimated 10% to 15% of adults worldwide, with more than 50 million people in the United States reporting it; only 1% to 2% report it as severely bothersome or disabling, and nearly 3 million US veterans received service-connected disability compensation at the end of fiscal year 2024.
  • A meta-analysis found suicidal ideation in 19.5% and suicide attempts in 1.9% of patients with tinnitus; the guideline makes a strong recommendation to inquire about risks for self-harm in patients with bothersome tinnitus.
  • Natural history data show complete resolution in 18% over 5 years in the Blue Mountain Hearing Study and 18% over an average of 4 years in a UK Biobank sample; when tinnitus persisted, bothersomeness was unchanged for 82%, with improvement and worsening each occurring in 9%.
  • The guideline recommends CBT (Grade A), hearing aid evaluation for hearing difficulties, and cochlear implant referral when audiologic criteria are met; it offers sound enrichment and bimodal neuromodulation as options, and recommends against routine neuroradiologic imaging, antidepressants/anticonvulsants/anxiolytics/intratympanic medications, dietary supplements, and rTMS. For bimodal neuromodulation, TENT-A3 reported 63.3% achieving ≥7-point THI reduction with sound-only, an additional 43.3% with added tongue stimulation, and 58.6% vs 43.2% responder rates for bimodal vs sound-only in patients with THI ≥38.

Methods

  • This update was developed using the AAO-HNSF Clinical Practice Guideline Development Manual (3rd edition), with a 20-member multidisciplinary Guideline Update Group, BRIDGE-Wiz decision support, GLIA appraisal, peer review, and open public comment.
  • Literature searches identified 43 clinical practice guidelines, 322 systematic reviews, 13 meta-analyses, and 681 RCTs published in 2014 or later; after screening, the group retained 28 CPGs, 223 systematic reviews, 5 meta-analyses, and 362 RCTs, with evidence through March 2025.
  • Key action statements were graded by aggregate evidence quality and benefit-harm balance; new statements addressed self-harm, somatosensory tinnitus, cochlear implantation, bimodal neuromodulation, and follow-up.

Limitations

  • Stated: few studies specifically investigate the diagnostic yield or impact of history and examination; many trials and reviews have methodological concerns, heterogeneity, small samples, risk of bias, and imprecise effect estimates; bimodal neuromodulation trials were industry-sponsored, the pivotal study lacked a sham control, and long-term outcomes are not available; rTMS benefits were short-term and often not clinically significant or durable.
  • Stated: the guideline notes lack of consensus on optimal follow-up intervals, outcome measures, and minimal clinically important differences; no single standard tinnitus questionnaire exists; recommendations may not apply to patients with identifiable causes other than sensorineural hearing loss, objective or pulsatile tinnitus, transient ear noise, or complex auditory hallucinations.
  • Evident from the text: this is a guideline synthesis rather than a new primary study, and many recommendations rely on observational studies or expert consensus where data were lacking; several statements are “Option” or based on Grade C evidence, and the group identified access, cost, insurance coverage, and implementation barriers as limitations.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1002/ohn.70417

Cites

352 of 352 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 18 Not valid · 257 Not checked · 112 Own results and interpretations

135 more claims

Create a free account to see all 387 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 106
  • It may state two separate claims as one. 181
  • The quote only partly states this claim. 10

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Items 201–352 of 352

Research works printed but not linked: 8

  1. 10.1044/jshr.3401.197 · DOI · Paper page
  2. UK NGC. Evidence review for assessing quality of life: tinnitus: assessment and management;2020.
  3. Henry JA, 2020, Tinnitus: A Self‐Management Guide for the Ringing in Your Ears
  4. Pichora‐FullerMKSP HammillA et al. Evaluation and treatment of tinnitus: comparative effectiveness. Comparative Effectiveness Review No. 122. Agency for Healthcare Research and Quality.www.effectivehealthcare.ahrq.gov/reports/finalcfm
  5. Savage J, 2009, Waddell A. Tinnitus, BMJ Clin Evid, 2009
  6. Mahendru B, 2013, Medknow Publications & Media Pvt Ltd B‐9, Kanara Business Centre, Off Link, S90
  7. Coles R, 1992, Tinnitus severity gradings: cross‐sectional studies, Tinnitus, 91, 453
  8. Sivakumar M, 2023, Efficacy of intratympanic steroid injection versus 4% lignocaine in idiopathic tinnitus, Int J Acad Med Pharm, 5, 1671

Cited by

See all 1

Metadata

Authors
Adams, M. E., Cramer, J. D., Tunkel, D. E., Lee, V. S., Bourgeois, J. A., Eshraghi, A. A., Fagelson, M. A., White, K. B., Juliano, A. F., Kim, H., Kuzbyt, B., Lynch, P. A., Miller, M., Noonan, K. Y., Roehm, P. C., Schaffer, S. R., Sherlock, L. P., Steenerson, K. K., Wallhagen, M., Zaugg, T. L., & Akrami, Z.
Affiliations
  • University of Michigan (US)
  • Wayne State University (US)
  • Johns Hopkins University (US)
  • University of Illinois Chicago (US)
  • University of California Davis Medical Center (US)
  • University of Miami (US)
  • East Tennessee State University (US)
  • University of North Carolina at Chapel Hill (US)
  • Massachusetts Eye and Ear Infirmary (US)
  • Medical College of Wisconsin (US)
  • American Tinnitus Association (US)
  • Cedars-Sinai Medical Center (US)
  • Tufts Medical Center (US)
  • St. Luke's University Health Network (US)
  • Hospital of the University of Pennsylvania (US)
  • Walter Reed National Military Medical Center (US)
  • Stanford University (US)
  • University of California, San Francisco (US)
  • American Academy of Otolaryngology — Head and Neck Surgery (US)
Corresponding author
Adams, Meredith E.
Venue
Otolaryngology–Head and Neck Surgery
Publisher
Wiley
Published
2026-10
Volume
175
Issue
S1
Pages
S1-S62
ISSN
  • 0161-6439 (ISSN-L)
  • 0194-5998
  • 1097-6817
OpenAlex
W7221507901
Cited by
1
References
351
Citations by year
2026: 1
FWCI
2.54
Type
journal article
Language
en
Open access
Licence
Locations
  • Otolaryngology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense
  • American Tinnitus Association
  • American Academy of Otolaryngology-Head and Neck Surgery
  • Kaiser Permanente
  • University of Miami
  • National Institutes of Health
  • Uniformed Services University of the Health Sciences
  • National Institute on Deafness and Other Communication Disorders
Topics
  • Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
  • Health Sciences › Health Professions › Speech and Hearing › Hearing Loss and Rehabilitation
  • Physical Sciences › Physics and Astronomy › Acoustics and Ultrasonics › Noise Effects and Management
Keywords
tinnitus, tinnitus evaluation, tinnitus treatment, quality of life, self-harm risk, diagnostic testing
MeSH terms
Humans, Quality of Life, Tinnitus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.